Glaukos Corporation
GKOS
Rang in aandelen
#2086
Glaukos Corporation operates as an ophthalmic medical technology and... Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma. Its promising product pipeline features iStent Infinite, a three-stent system intended for standalone use in patients with refractory glaucoma, as well as iDose TR, a targeted injectable implant that utilizes Glaukos's micro-scale device platform to deliver therapeutic levels of medication. The company distributes its products through a direct sales organization and a network of distributors, serving markets across the United States and internationally. Glaukos Corporation, founded in 1998, is headquartered in San Clemente, California.
Aandeelprijs
$166.79
Marktkapitalisatie
$9.84B
Verandering (1 dag)
1.44%
Verandering (1 jaar)
91.34%
Land
US
Handel Glaukos Corporation (GKOS)
Categorie
Healthcare
EPS voor Glaukos Corporation (GKOS)
EPS per June 2026 TTM: $-3.25
Volgens de laatste financiële rapporten en de aandelenkoers van Glaukos Corporation is de huidige EPS van het bedrijf (TTM) $-3.25. Eind 2023 had het bedrijf een EPS van $-2.78, een stijging ten opzichte van de EPS van 2022 die $-2.09 bedroeg.
EPS-geschiedenis van Glaukos Corporation van 2012 tot 2026
EPS aan het einde van elk jaar
| Jaar | EPS | Wijzigen |
|---|---|---|
| 2026 (TTM) | $-3.25 | 17.33% |
| 2024 | $-2.77 | -0.36% |
| 2023 | $-2.78 | 33.01% |
| 2022 | $-2.09 | 95.33% |
| 2021 | $-1.07 | -60.37% |
| 2020 | $-2.70 | -758.54% |
| 2019 | $0.41 | -210.81% |
| 2018 | $-0.37 | 13,603.70% |
| 2017 | 0.00 | -101.93% |
| 2016 | $0.14 | -106.57% |
| 2015 | $-2.13 | 334.69% |
| 2014 | $-0.49 | -3.92% |
| 2013 | $-0.51 | -94.76% |
| 2012 | $-9.73 | 0.00% |
EPS van vergelijkbare bedrijven of concurrenten
| Bedrijf | EPS | EPS-verschil | Land |
|---|---|---|---|
| $3.11 | -195.69% |
US
|
|
| $3.59 | -210.46% |
IE
|
|
| $9.73 | -399.38% |
US
|
|
| $2.48 | -176.31% |
US
|
|
| - | - |
DE
|
